132 related articles for article (PubMed ID: 37178426)
21. A novel molecular subtyping based on multi-omics analysis for prognosis predicting in colorectal melanoma: A 16-year prospective multicentric study.
Liu C; Cheng X; Han K; Hong L; Hao S; Sun X; Xu J; Li B; Jin D; Tian W; Jin Y; Wang Y; Fang W; Bao X; Zhao P; Chen D
Cancer Lett; 2024 Mar; 585():216663. PubMed ID: 38246221
[TBL] [Abstract][Full Text] [Related]
22. Multi-omics Analysis Identifies Hypoxia Subtypes and S100A2 as an Immunosuppressive Factor in Cervical Cancer.
Yang J; Wan S; Zhao M; Cai H; Gao Y; Wang H
Reprod Sci; 2024 Jan; 31(1):107-121. PubMed ID: 37648942
[TBL] [Abstract][Full Text] [Related]
23. Ovarian cancer beyond imaging: integration of AI and multiomics biomarkers.
Hatamikia S; Nougaret S; Panico C; Avesani G; Nero C; Boldrini L; Sala E; Woitek R
Eur Radiol Exp; 2023 Sep; 7(1):50. PubMed ID: 37700218
[TBL] [Abstract][Full Text] [Related]
24. Metabolism pathway-based subtyping in endometrial cancer: An integrated study by multi-omics analysis and machine learning algorithms.
Liu X; Wang W; Zhang X; Liang J; Feng D; Li Y; Xue M; Ling B
Mol Ther Nucleic Acids; 2024 Jun; 35(2):102155. PubMed ID: 38495844
[TBL] [Abstract][Full Text] [Related]
25. Attention-based GCN integrates multi-omics data for breast cancer subtype classification and patient-specific gene marker identification.
Guo H; Lv X; Li Y; Li M
Brief Funct Genomics; 2023 Nov; 22(5):463-474. PubMed ID: 37114942
[TBL] [Abstract][Full Text] [Related]
26. Extensive three-dimensional intratumor proteomic heterogeneity revealed by multiregion sampling in high-grade serous ovarian tumor specimens.
Hunt AL; Bateman NW; Barakat W; Makohon-Moore S; Hood BL; Conrads KA; Zhou M; Calvert V; Pierobon M; Loffredo J; Litzi TJ; Oliver J; Mitchell D; Gist G; Rojas C; Blanton B; Robinson EL; Odunsi K; Sood AK; Casablanca Y; Darcy KM; Shriver CD; Petricoin EF; Rao UNM; Maxwell GL; Conrads TP
iScience; 2021 Jul; 24(7):102757. PubMed ID: 34278265
[TBL] [Abstract][Full Text] [Related]
27. Integrated Multi-Omic Analysis Reveals Immunosuppressive Phenotype Associated with Poor Outcomes in High-Grade Serous Ovarian Cancer.
Keathley R; Kocherginsky M; Davuluri R; Matei D
Cancers (Basel); 2023 Jul; 15(14):. PubMed ID: 37509311
[TBL] [Abstract][Full Text] [Related]
28. Statistical Methods for Integrative Clustering of Multi-omics Data.
Chalise P; Kwon D; Fridley BL; Mo Q
Methods Mol Biol; 2023; 2629():73-93. PubMed ID: 36929074
[TBL] [Abstract][Full Text] [Related]
29. Omics sciences and precision medicine in breast and ovarian cancer.
Bonetti G; Madeo G; Michelini S; Ricci M; Cestari M; Michelini S; Gadler M; Benedetti S; Guerri G; Cristofoli F; Generali D; Donofrio CA; Cominetti M; Fioravanti A; Riccio L; Bernini A; Fulcheri E; Stuppia L; Gatta V; Cecchin S; Marceddu G; Bertelli M
Clin Ter; 2023; 174(Suppl 2(6)):104-118. PubMed ID: 37994754
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of the prognostic potential of histopathological subtyping in high-grade serous ovarian carcinoma.
Zelisse HS; Hwan RA; van de Vijver MJ; Dijk F; Mom CH; Hooijer GKJ; van Gent MDJM; Snijders MLH
Virchows Arch; 2024 Apr; ():. PubMed ID: 38622323
[TBL] [Abstract][Full Text] [Related]
31. Multi-omics integration analysis unveils heterogeneity in breast cancer at the individual level.
Zhao Z; Jin T; Chen B; Dong Q; Liu M; Guo J; Song X; Li Y; Chen T; Han H; Liang H; Gu Y
Cell Cycle; 2023 Oct; 22(20):2229-2244. PubMed ID: 37974462
[TBL] [Abstract][Full Text] [Related]
32. Metabolome subtyping reveals multi-omics characteristics and biological heterogeneity in major psychiatric disorders.
Hao M; Qin Y; Li Y; Tang Y; Ma Z; Tan J; Jin L; Wang F; Gong X
Psychiatry Res; 2023 Dec; 330():115605. PubMed ID: 38006718
[TBL] [Abstract][Full Text] [Related]
33. Information-incorporated sparse convex clustering for disease subtyping.
Zhang X; Liu CT
Bioinformatics; 2023 Jul; 39(7):. PubMed ID: 37382570
[TBL] [Abstract][Full Text] [Related]
34. Immune-and Metabolism-Associated Molecular Classification of Ovarian Cancer.
Chen Z; Jiang W; Li Z; Zong Y; Deng G
Front Oncol; 2022; 12():877369. PubMed ID: 35646692
[TBL] [Abstract][Full Text] [Related]
35. Unveiling the novel immune and molecular signatures of ovarian cancer: insights and innovations from single-cell sequencing.
Li Z; Gu H; Xu X; Tian Y; Huang X; Du Y
Front Immunol; 2023; 14():1288027. PubMed ID: 38022625
[TBL] [Abstract][Full Text] [Related]
36. Immune perturbation network identifies an EMT subtype with chromosomal instability and tumor immune-desert microenvironment.
Xu H; Fu X; Liu B; Weng S; Guo C; Quan L; Liu L; Wang L; Xing Z; Cheng Q; Luo P; Chen K; Liu Z; Han X
iScience; 2023 Oct; 26(10):107871. PubMed ID: 37766999
[TBL] [Abstract][Full Text] [Related]
37. A robust primary liver cancer subtype related to prognosis and drug response based on a multiple combined classifying strategy.
Deng J; Lai G; Zhang C; Li K; Zhu W; Xie B; Zhong X
Heliyon; 2024 Feb; 10(3):e25570. PubMed ID: 38352751
[TBL] [Abstract][Full Text] [Related]
38. Development of gene panel for predicting recurrence in early-stage cervical cancer patients.
Ma Y; Zhu W
Environ Toxicol; 2024 Apr; ():. PubMed ID: 38563455
[TBL] [Abstract][Full Text] [Related]
39. vWCluster: Vector-valued optimal transport for network based clustering using multi-omics data in breast cancer.
Zhu J; Oh JH; Deasy JO; Tannenbaum AR
PLoS One; 2022; 17(3):e0265150. PubMed ID: 35286348
[TBL] [Abstract][Full Text] [Related]
40. Unlocking ovarian cancer heterogeneity: advancing immunotherapy through single-cell transcriptomics.
Balan D; Kampan NC; Plebanski M; Abd Aziz NH
Front Oncol; 2024; 14():1388663. PubMed ID: 38873253
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
